|
|
 |
|
| | |
| | | | | | |
sequence
|
|
PR:000000276 |
tumor necrosis factor ligand superfamily member 6 isoform FasL
|
FASLG/iso:FasL
|
"A tumor necrosis factor ligand superfamily member 6 that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P48023-1 or a 1:1 ortholog thereof." [PRO:CNA, PRO:DAN]
|
|
|
|
|
|
|
| | | | |
| | | | |
sequence
|
|
PR:000000278 |
tumor necrosis factor ligand superfamily member 6 isoform FasL sequence variant F273L
|
FASLG/iso:FasL/var:F273L
|
"A tumor necrosis factor ligand superfamily member 6 isoform FasL that has a Leu residue at the position equivalent to Phe-273 of the amino acid sequence represented by UniProtKB:P41047-1. Example: UniProtKB:P41047-1, Phe-273, CHEBI:30006." [PMID:7495745, PRO:CNA, PRO:DAN]
|
|
|
|
|
|
|
| | | | | | |
| | |
organism-sequence
|
|
PR:000036782 |
tumor necrosis factor ligand superfamily member 6 isoform FasL sequence variant F273L (human)
|
hFASLG/iso:FasL/var:F273L
|
"A tumor necrosis factor ligand superfamily member 6 isoform FasL sequence variant F273L that is encoded in the genome of human. The variation occurs at the position equivalent to Phe-275 of the amino acid sequence represented by UniProtKB:P48023-1. UniProtKB:P48023-1, Phe-275, CHEBI:30006." [PRO:DAN]
|
Yes |
|
|
|
|
|
| | | | | | |
| | |
organism-sequence
|
|
PR:000036783 |
tumor necrosis factor ligand superfamily member 6 isoform FasL sequence variant F273L (mouse)
|
mFASLG/iso:FasL/var:F273L
|
"A tumor necrosis factor ligand superfamily member 6 isoform FasL sequence variant F273L that is encoded in the genome of mouse. The variation occurs at the position equivalent to Phe-273 of the amino acid sequence represented by UniProtKB:P41047-1. UniProtKB:P41047-1, Phe-273, CHEBI:30006." [PMID:7495745, PRO:DAN]
|
Yes |
|
|
|
|
|
| | | | |
| | | | |
organism-sequence
|
|
PR:P41047-1 |
tumor necrosis factor ligand superfamily member 6 isoform FasL (mouse)
|
mFASLG/iso:FasL
|
"A tumor necrosis factor ligand superfamily member 6 isoform FasL that is encoded in the genome of mouse." [PRO:CNA]
|
Yes |
|
|
|
|
|
| | | | | | |
| | |
organism-sequence
|
|
PR:000036783 |
tumor necrosis factor ligand superfamily member 6 isoform FasL sequence variant F273L (mouse)
|
mFASLG/iso:FasL/var:F273L
|
"A tumor necrosis factor ligand superfamily member 6 isoform FasL sequence variant F273L that is encoded in the genome of mouse. The variation occurs at the position equivalent to Phe-273 of the amino acid sequence represented by UniProtKB:P41047-1. UniProtKB:P41047-1, Phe-273, CHEBI:30006." [PMID:7495745, PRO:DAN]
|
Yes |
|
|
|
|
|
| | | | |
| | | | |
organism-sequence
|
|
PR:P48023-1 |
tumor necrosis factor ligand superfamily member 6 isoform FasL (human)
|
hFASLG/iso:FasL
|
"A tumor necrosis factor ligand superfamily member 6 isoform FasL that is encoded in the genome of human." [PRO:CNA]
|
Yes |
|
|
|
|
|
| | | | | | |
| | |
organism-sequence
|
|
PR:000036782 |
tumor necrosis factor ligand superfamily member 6 isoform FasL sequence variant F273L (human)
|
hFASLG/iso:FasL/var:F273L
|
"A tumor necrosis factor ligand superfamily member 6 isoform FasL sequence variant F273L that is encoded in the genome of human. The variation occurs at the position equivalent to Phe-275 of the amino acid sequence represented by UniProtKB:P48023-1. UniProtKB:P48023-1, Phe-275, CHEBI:30006." [PRO:DAN]
|
Yes |
|
|
|
|
|
| | | | | | |
| | |
organism-modification
|
|
PR:000036458 |
tumor necrosis factor ligand superfamily member 6 isoform FasL N-glycosylated 1 (human)
|
hFASLG/iso:FasL/NGlyco:1
|
"A tumor necrosis factor ligand superfamily member 6 isoform FasL N-glycosylated 1 in human. UniProtKB:P48023-1, Asn-184/Asn-250/Asn-260, MOD:00160." [PMID:9405425, PRO:CNA, PRO:DAN]
|
Yes |
|
|
|
|
|
| | | | | | |
| | |
organism-modification
|
|
PR:000036459 |
tumor necrosis factor ligand superfamily member 6 isoform FasL soluble form (human)
|
hFASLG/iso:FasL/Clv:soluble
|
"A tumor necrosis factor ligand superfamily member 6 isoform FasL soluble form in human. UniProtKB:P48023-1, 130-281." [PMID:7536672, PMID:9228058, PMID:9396774, PMID:9405425, PRO:CNA]
|
Yes |
|
|
|
|
|
| | | | |
| | | | |
modification
|
|
PR:000000432 |
tumor necrosis factor ligand superfamily member 6 isoform FasL glycosylated form
|
FASLG/iso:FasL/GlycoRes+
|
"A tumor necrosis factor ligand superfamily member 6 isoform FasL that includes at least one glycosylated residue." [PRO:CNA]
|
|
|
|
|
|
|
| | | | | | |
| | |
modification
|
|
PR:000000546 |
tumor necrosis factor ligand superfamily member 6 isoform FasL N-glycosylated 1
|
FASLG/iso:FasL/NGlyco:1
|
"A tumor necrosis factor ligand superfamily member 6 isoform FasL glycosylated form that has been N-glycosylated at the Asn residues within the N-glycosylation sites located in the C-terminal extracellular region. Example: UniProtKB:P48023-1, Asn-184/Asn-250/Asn-260, MOD:00160." [PMID:9405425]
|
|
|
|
|
|
|
| | | | | | | | |
|
organism-modification
|
|
PR:000036458 |
tumor necrosis factor ligand superfamily member 6 isoform FasL N-glycosylated 1 (human)
|
hFASLG/iso:FasL/NGlyco:1
|
"A tumor necrosis factor ligand superfamily member 6 isoform FasL N-glycosylated 1 in human. UniProtKB:P48023-1, Asn-184/Asn-250/Asn-260, MOD:00160." [PMID:9405425, PRO:CNA, PRO:DAN]
|
Yes |
|
|
|
|
|
| | | | |
| | | | |
modification
|
|
PR:000000547 |
tumor necrosis factor ligand superfamily member 6 isoform FasL soluble form
|
FASLG/iso:FasL/Clv:soluble
|
"A tumor necrosis factor ligand superfamily member 6 isoform FasL that is the soluble N-terminal portion after ADAM10 processing." [PRO:CNA, PRO:DAN]
|
|
|
|
|
|
|
| | | | | | |
| | |
organism-modification
|
|
PR:000036459 |
tumor necrosis factor ligand superfamily member 6 isoform FasL soluble form (human)
|
hFASLG/iso:FasL/Clv:soluble
|
"A tumor necrosis factor ligand superfamily member 6 isoform FasL soluble form in human. UniProtKB:P48023-1, 130-281." [PMID:7536672, PMID:9228058, PMID:9396774, PMID:9405425, PRO:CNA]
|
Yes |
|
|
|
